YTP-21509-43392
6 vaccinations
4 coded responses
38 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 980 / WA
- Registered
- 2021-03-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-04
Dose 1 — Pfizer-BioNTech
-
2021-03-06
Registered in v-safe
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-10
- 2021-03-11
- 2021-03-18
-
2021-03-25
Dose 2 — Pfizer-BioNTech
-
2021-03-25
Health check-in — day 0, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-26
Survey response — days 1–6 daily, dose 2MedDRA: Erythema, Pre-existing disease — Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesFree text: Red hands/feet but symptom of Xeloda I take 14 of 21 days. Shot received on day 14.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-28
- 2021-03-29
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-06-26
-
2021-08-30
Dose 3 — Pfizer-BioNTech
- 2021-09-23
- 2021-09-23
- 2021-09-27
-
2021-10-04
Survey response — day 35, dose 3MedDRA: Breast cancer, Human epidermal growth factor receptor positive, Metastases to liver, Office visit, Pre-existing disease, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Metastatic Breast Cancer 2nd Mutation Her2+ Diagnosed 03/2020 in liver. Side effects of Capcetibane, worsened red hand foot syndrome. New treatment plan pending. Prior MBC HR+ Diagnosed 11/2016 Original to left breast ER+ 04/2012 · Healthcare visit (other): Routine visits every 3 weeks but added biopsy 9/29MedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Report sent to call center — day 35, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2021-10-12
- 2021-10-12
- 2021-12-01
-
2022-02-12
Dose 4 — Pfizer-BioNTech
-
2022-02-14
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-02-15
- 2022-02-18
- 2022-03-05
-
2022-03-14
Survey response — day 28, dose 4MedDRA: Adverse drug reaction, Chemotherapy — Feeling: Good · Be unable to do your normal daily activitiesFree text: Persistent mouth sores and fatigue related to oral chemo 'Everolimus' 7.5 mg daily. Dosage adjusted down as result. Feeling better this week.MedDRA releases: 2024-11 · check-in free text available
- 2022-03-19
- 2022-03-26
- 2022-05-18
-
2022-07-26
Dose 5 — Pfizer-BioNTech
- 2022-08-16
-
2022-08-16
Survey response — 6 months, dose 4MedDRA: Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: On a break from treatment for MBC in liver to get on top of side effects before switching to a new plan. Not COVID related but I did get shot 5 Phizer.MedDRA releases: 2024-11 · check-in free text available
- 2022-08-31
- 2022-09-09
-
2022-09-29
Dose 6 — Pfizer-BioNTech
- 2022-10-25
- 2023-01-24
- 2023-03-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | |
| 2 | 2021-03-25 | Pfizer-BioNTech | |
| 3 | 2021-08-30 | Pfizer-BioNTech | No |
| 4 | 2022-02-12 | Pfizer-BioNTech | No |
| 5 | 2022-07-26 | Pfizer-BioNTech | No |
| 6 | 2022-09-29 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-04 | Unsuccessful |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Red hands/feet but symptom of Xeloda I take 14 of 21 days. Shot received on day 14.
Release 10 — day 35, dose 3
Symptoms: Metastatic Breast Cancer 2nd Mutation Her2+ Diagnosed 03/2020 in liver. Side effects of Capcetibane, worsened red hand foot syndrome. New treatment plan pending. Prior MBC HR+ Diagnosed 11/2016 Original to left breast ER+ 04/2012
Healthcare visit (other): Routine visits every 3 weeks but added biopsy 9/29
Release 11 — day 28, dose 4
Symptoms: Persistent mouth sores and fatigue related to oral chemo 'Everolimus' 7.5 mg daily. Dosage adjusted down as result. Feeling better this week.
Release 12 — 6 months, dose 4
Symptoms: On a break from treatment for MBC in liver to get on top of side effects before switching to a new plan. Not COVID related but I did get shot 5 Phizer.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Adverse drug reaction | · | · | ✓ |
| SD | Breast cancer | · | · | ✓ |
| SD | Chemotherapy | · | · | ✓ |
| SD | Human epidermal growth factor receptor positive | · | · | ✓ |
| SD | Metastases to liver | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release